Literature DB >> 35918562

Predicting bacterial infection risk in patients with ANCA-associated vasculitis in southwest China: development of a new nomogram.

Naidan Zhang1, Jiaxiang Sun1, Chaixia Ji1, Xiao Bao2, Chenliang Yuan3.   

Abstract

OBJECTIVES: The aim of this study was to develop and assess a risk nomogram of bacterial infection in patients with ANCA-associated vasculitis (AAV) in southwest China.
METHOD: We established a prediction model based on a training dataset of 249 AAV patients. The least absolute shrinkage and selection operator (Lasso) was used to screen feature variables. Multivariate logistic regression analysis was used to build a prediction model for feature variables. Nomogram was used to predict the risk of bacterial infection in AAV patients. Receiver operating characteristic (ROC) curve was used to evaluate and verify the prediction accuracy of the model. Calibration and clinical useful range was assessed using calibration curve and decision curve analysis, respectively.
RESULTS: Bactericidal permeability enhancement protein of ANCAs (BPI-ANCAs), procalcitonin (PCT), and white blood cell (WBC) were the characteristic variables in this study. Nomogram showed that positive BPI-ANCAs and PCT had higher positive predictive value for bacterial infection in AAV patients. The area under curve (AUC) of the model was 0.703 (95% confidence interval: 0.640-0.766). In the validation model, the AUC was 0.745 (95% confidence interval: 0.617-0.872). Decision curve analysis showed that the nonadherence nomogram was clinically useful within the threshold probability range of 0.31-0.85.
CONCLUSIONS: Nomogram combined with BPI-ANCAs and PCT has the guiding significance for predicting bacterial infection risk in AAV. As an ANCA-specific autoantibody, BPI-ANCAs is helpful for clinicians to understand the role of specific autoantibodies in the pathogenesis of AAV. Key Points • BPI-ANCAs, PCT, and WBC could predict bacterial infection in AAV patients. • Nomogram showed that positive BPI-ANCAs had a high positive predictive value for bacterial infection in AAV patients.
© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  ANCA-associated vasculitis; Bacterial infection; Laboratory data; Nomogram; Predictors

Mesh:

Substances:

Year:  2022        PMID: 35918562     DOI: 10.1007/s10067-022-06314-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  37 in total

Review 1.  Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  Cord H Sunderkötter; Bernhard Zelger; Ko-Ron Chen; Luis Requena; Warren Piette; J Andrew Carlson; Jan Dutz; Peter Lamprecht; Alfred Mahr; Elisabeth Aberer; Victoria P Werth; David A Wetter; Seiji Kawana; Raashid Luqmani; Camille Frances; Joseph Jorizzo; J Richard Watts; Dieter Metze; Marzia Caproni; Erkan Alpsoy; Jeffrey P Callen; David Fiorentino; Peter A Merkel; Ronald J Falk; J Charles Jennette
Journal:  Arthritis Rheumatol       Date:  2018-02       Impact factor: 10.995

2.  Platelet counts as a biomarker in ANCA-associated vasculitis.

Authors:  P Willeke; P Kümpers; B Schlüter; A Limani; H Becker; H Schotte
Journal:  Scand J Rheumatol       Date:  2015-03-06       Impact factor: 3.641

3.  Prevalence and Risk Factors for Major Infections in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Influence on the Disease Outcome.

Authors:  Eloi Garcia-Vives; Alfons Segarra-Medrano; Ferran Martinez-Valle; Irene Agraz; Roser Solans-Laque
Journal:  J Rheumatol       Date:  2019-06-15       Impact factor: 4.666

4.  Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.

Authors:  Michael Walsh; Peter A Merkel; Chen-Au Peh; Wladimir M Szpirt; Xavier Puéchal; Shouichi Fujimoto; Carmel M Hawley; Nader Khalidi; Oliver Floßmann; Ron Wald; Louis P Girard; Adeera Levin; Gina Gregorini; Lorraine Harper; William F Clark; Christian Pagnoux; Ulrich Specks; Lucy Smyth; Vladimir Tesar; Toshiko Ito-Ihara; Janak Rashme de Zoysa; Wojciech Szczeklik; Luis Felipe Flores-Suárez; Simon Carette; Loïc Guillevin; Charles D Pusey; Alina L Casian; Biljana Brezina; Andrea Mazzetti; Carol A McAlear; Elizabeth Broadhurst; Donna Reidlinger; Samir Mehta; Natalie Ives; David R W Jayne
Journal:  N Engl J Med       Date:  2020-02-13       Impact factor: 91.245

5.  Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas.

Authors:  Mary-Ann El Sharouni; Tasnia Ahmed; Alexander H R Varey; Sjoerd G Elias; Arjen J Witkamp; Vigfús Sigurdsson; Karijn P M Suijkerbuijk; Paul J van Diest; Richard A Scolyer; Carla H van Gils; John F Thompson; Willeke A M Blokx; Serigne N Lo
Journal:  J Clin Oncol       Date:  2021-02-18       Impact factor: 44.544

6.  Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies.

Authors:  Magdalena Mosakowska; Dorota Brodowska Kania; Katarzyna Szamotulska; Aleksandra Rymarz; Stanisław Niemczyk
Journal:  BMC Nephrol       Date:  2021-08-26       Impact factor: 2.388

Review 7.  Severe infections in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides receiving rituximab: A meta-analysis.

Authors:  Clémence Thery-Casari; Romain Euvrard; Sabine Mainbourg; Stéphane Durupt; Quitterie Reynaud; Isabelle Durieu; Alexandre Belot; Hervé Lobbes; Natalia Cabrera; Jean-Christophe Lega
Journal:  Autoimmun Rev       Date:  2020-03-12       Impact factor: 9.754

8.  Aggregatibacter aphrophilus infective endocarditis confirmed by broad-range PCR diagnosis: A case report.

Authors:  Koji Hirano; Toshiya Tokui; Masahiro Inagaki; Taro Fujii; Yasumi Maze; Hirokazu Toyoshima
Journal:  Int J Surg Case Rep       Date:  2017-01-19

9.  Identification of differentially expressed genes and pathways in kidney of ANCA-associated vasculitis by integrated bioinformatics analysis.

Authors:  Xu Deng; Junying Gao; Fei Zhao
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

10.  Diagnostic Value of Procalcitonin in ANCA-Associated Vasculitis (AAV) to Differentiate Between Disease Activity, Infection and Drug Hypersensitivity.

Authors:  K Herrmann; S Schinke; E Csernok; F Moosig; J U Holle
Journal:  Open Rheumatol J       Date:  2015-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.